Cargando…

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

In animal models, the incretin hormone GLP-1 affects Alzheimer’s disease (AD). We hypothesized that treatment with GLP-1 or an analog of GLP-1 would prevent accumulation of Aβ and raise, or prevent decline of, glucose metabolism (CMR(glc)) in AD. In this 26-week trial, we randomized 38 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gejl, Michael, Gjedde, Albert, Egefjord, Lærke, Møller, Arne, Hansen, Søren B., Vang, Kim, Rodell, Anders, Brændgaard, Hans, Gottrup, Hanne, Schacht, Anna, Møller, Niels, Brock, Birgitte, Rungby, Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877513/ https://www.ncbi.nlm.nih.gov/pubmed/27252647 http://dx.doi.org/10.3389/fnagi.2016.00108

Ejemplares similares

Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
por: Gejl, Michael, et al.
Publicado: (2017)

Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain
por: Gejl, Michael, et al.
Publicado: (2013)

Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia
por: Gejl, Michael, et al.
Publicado: (2014)

Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats
por: DellaValle, Brian, et al.
Publicado: (2016)

Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial
por: Gejl, Michael, et al.
Publicado: (2017)

Washout allometric reference method (WARM) for parametric analysis of [(11)C]PIB in human brains
por: Rodell, Anders, et al.
Publicado: (2013)

Low Residual CBF Variability in Alzheimer’s Disease after Correction for CO(2) Effect
por: Rodell, Anders Bertil, et al.
Publicado: (2012)

Blood-brain transfer of Pittsburgh compound B in humans
por: Gjedde, Albert, et al.
Publicado: (2013)

Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma
por: DellaValle, Brian, et al.
Publicado: (2016)

The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease
por: Ismail, Rola, et al.
Publicado: (2018)

Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?
por: Egefjord, Lærke, et al.
Publicado: (2009)

PiB Fails to Map Amyloid Deposits in Cerebral Cortex of Aged Dogs with Canine Cognitive Dysfunction
por: Fast, Rikke, et al.
Publicado: (2013)

Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients
por: Stender, Johan, et al.
Publicado: (2015)

Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease
por: Nielsen, Rune B., et al.
Publicado: (2020)

Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes
por: Melchiorsen, Josefine U, et al.
Publicado: (2023)

Systematic medication review and health-related outcome in elderly patients acutely admitted to an orthopaedic ward: a randomised controlled study
por: Lisby, Marianne, et al.
Publicado: (2010)

Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover study
por: Wodschow, Helena Zander, et al.
Publicado: (2023)

Oral GLP1 Analog: Where Does the Tide Go?
por: Gardner, Hannah, et al.
Publicado: (2020)

N‐terminal alterations turn the gut hormone GLP‐2 into an antagonist with gradual loss of GLP‐2 receptor selectivity towards more GLP‐1 receptor interaction
por: Gabe, Maria Buur Nordskov, et al.
Publicado: (2022)

Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy
por: Kjeldsen, Sasha A.S., et al.
Publicado: (2023)

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
por: Rowlands, Jordan, et al.
Publicado: (2018)

Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
por: Niu, Xianli, et al.
Publicado: (2020)

Use of GLP‐1 receptor agonists and subsequent risk of alcohol‐related events. A nationwide register‐based cohort and self‐controlled case series study
por: Wium‐Andersen, Ida Kim, et al.
Publicado: (2022)

GLP-1 Analog Alleviated Cognitive Dysfunction in Aged Rats Anaesthetized with Sevoflurane
por: Zhang, Qin, et al.
Publicado: (2022)

Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy
por: Shi, Shaomin, et al.
Publicado: (2023)

Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome
por: Maxel, Trine, et al.
Publicado: (2017)

Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial
por: Tolstrup, Lærke K., et al.
Publicado: (2022)

Associations between waist circumference, metabolic risk and executive function in adolescents: A cross-sectional mediation analysis
por: Bugge, Anna, et al.
Publicado: (2018)

Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson’s Disease
por: Fedorova, Tatyana Dmitrievna, et al.
Publicado: (2023)

Natural selection of mitochondria during somatic lifetime promotes healthy aging
por: Rodell, Anders, et al.
Publicado: (2013)

SAT028 Beneficial Effect On Intestinal Growth Of A Long-Acting GLP-2 Analog, HM15912, After Treatment Switching From Conventional GLP-2 Drug Or Other Long-Acting GLP-2 Analogs Under Clinical Development In Animal Model
por: Park, Cho Rong, et al.
Publicado: (2023)

Cerebral Blood Flow and Aβ-Amyloid Estimates by WARM Analysis of [(11)C]PiB Uptake Distinguish among and between Neurodegenerative Disorders and Aging
por: Rodell, Anders B., et al.
Publicado: (2017)

Blood Pressure Levels in Male Carriers of Arg82Cys in CD300LG
por: Støy, Julie, et al.
Publicado: (2014)

Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes
por: Gutierrez, Absalon D., et al.
Publicado: (2022)

The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial
por: Tolstrup, Lærke K., et al.
Publicado: (2020)

The zinc transporter Zip14 (SLC39a14) affects Beta-cell Function: Proteomics, Gene expression, and Insulin secretion studies in INS-1E cells
por: Maxel, Trine, et al.
Publicado: (2019)

Parallel declines in abundance of insects and insectivorous birds in Denmark over 22 years
por: Møller, Anders Pape
Publicado: (2019)

The Human GLP-1 Analog Liraglutide and the Pancreas: Evidence for the Absence of Structural Pancreatic Changes in Three Species
por: Nyborg, Niels C.B., et al.
Publicado: (2012)

Effect of the GLP-1 Analog Exendin-4 and Oxaliplatin on Intrahepatic Cholangiocarcinoma Cell Line and Mouse Model
por: Chen, Ben-Dong, et al.
Publicado: (2013)

Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications
por: Manandhar, Bikash, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_92ou3hfgplvpp68ekchs48u8v7